Authors: Huck, C Endl, J Walk, T Noessner, E Jung, G Wank, R Schendel, DJ

Citation: C. Huck et al., HLA-DR53 molecules restrict glutamic acid decarboxylase peptide presentation to T cells of a Type I diabetes patient: specification of the trimolecular HLA-peptide/T-cell receptor complex, DIABETOLOG, 44(1), 2001, pp. 70-80

Authors: Peakman, M Tree, TI Endl, J van Endert, P Atkinson, MA Roep, BO

Citation: M. Peakman et al., Characterization of preparations of GAD65, proinsulin, and the islet tyrosine phosphatase IA-2 for use in detection of autoreactive T-cells in type 1diabetes - Report of phase II of the second international immunology of diabetes society workshop for standardization of T-cell assays in type 1 diabetes, DIABETES, 50(8), 2001, pp. 1749-1754

Authors: Beales, PE Liddi, R Endl, J Kientsch-Engel, R Pozzilli, P

Citation: Pe. Beales et al., Intradermal administration of GAD & evaluation of diabetes incidence in mice: Possible relevance for skin tests in humans, AUTOIMMUN, 32(2), 2000, pp. 109-113

Authors: Kolm-Litty, V Berlo, S Bonifacio, E Bearzatto, M Engel, AM Christie, M Ziegler, AG Wild, T Endl, J

Citation: V. Kolm-litty et al., Human monoclonal antibodies isolated from type I diabetes patients define multiple epitopes in the protein tyrosine phosphatase-like IA-2 antigen, J IMMUNOL, 165(8), 2000, pp. 4676-4684